IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 4, 2024, 4:36 PM EST

IO Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
23.8123.6124.4411.081.681.98
Research & Development
69.5867.8346.9930.158.467.94
Operating Expenses
93.491.4471.4241.2310.159.91
Operating Income
-93.4-91.44-71.42-41.23-10.15-9.91
Interest Expense
---0.3-0.36-0.03-0.01
Interest & Investment Income
6.595.881.41---
Currency Exchange Gain (Loss)
-0.490.330.130.320.11-0.04
EBT Excluding Unusual Items
-87.3-85.23-70.19-41.28-10.06-9.96
Other Unusual Items
----26.54-1.99-0.78
Pretax Income
-87.3-85.23-70.19-67.81-12.04-10.74
Income Tax Expense
0.70.851.270.07--
Net Income
-88-86.08-71.46-67.88-12.04-10.74
Preferred Dividends & Other Adjustments
---7.112.551.77
Net Income to Common
-88-86.08-71.46-74.99-14.59-12.52
Shares Outstanding (Basic)
624429400
Shares Outstanding (Diluted)
624429400
Shares Change (YoY)
115.42%51.10%564.62%2346.74%--
EPS (Basic)
-1.42-1.98-2.48-17.30-82.36-70.64
EPS (Diluted)
-1.42-1.98-2.48-17.30-82.36-70.64
Free Cash Flow
-80.86-72.06-60.42-40.8-9.96-8.89
Free Cash Flow Per Share
-1.30-1.66-2.10-9.41-56.19-50.17
EBITDA
-93.16-91.23-71.32-41.23--
D&A For EBITDA
0.240.220.10--
EBIT
-93.4-91.44-71.42-41.23-10.15-9.91
Source: S&P Capital IQ. Standard template. Financial Sources.